Skip to main content Skip to navigation
RY610 Rat Anti-Mouse CD93 (C1qR)
Product Details
Down Arrow Up Arrow


BD OptiBuild™
Cd93; Ly68; C1qr1; C1qrp; Complement component C1q receptor
Mouse (Tested in Development)
Rat LEW, also known as Lewis IgG2a, κ
Pro-B cell line R2BFL derived from the fetal liver of a RAG-2-/-Bcl2-transgenic mouse
Flow cytometry (Qualified)
0.2 mg/ml
17064
Aqueous buffered solution containing ≤0.09% sodium azide.
RUO


Preparation And Storage

Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated to the dye under optimum conditions that minimize unconjugated dye and antibody.

Recommended Assay Procedures

BD® CompBeads can be used as surrogates to assess fluorescence spillover (compensation). When fluorochrome conjugated antibodies are bound to BD® CompBeads, they have spectral properties very similar to cells. However, for some fluorochromes there can be small differences in spectral emissions compared to cells, resulting in spillover values that differ when compared to biological controls. It is strongly recommended that when using a reagent for the first time, users compare the spillover on cells and BD® CompBeads to ensure that BD® CompBeads are appropriate for your specific cellular application.

Product Notices

  1. Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
  2. Please refer to http://regdocs.bd.com to access safety data sheets (SDS).
  3. For U.S. patents that may apply, see bd.com/patents.
  4. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
  5. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
  6. The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity. However, verification testing has not been performed on all conjugate lots.
  7. Please observe the following precautions: We recommend that special precautions be taken (such as wrapping vials, tubes, or racks in aluminum foil) to protect exposure of conjugated reagents, including cells stained with those reagents, to any room illumination. Absorption of visible light can significantly affect the emission spectra and quantum yield of tandem fluorochrome conjugates.
  8. For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.
  9. An isotype control should be used at the same concentration as the antibody of interest.
  10. CF™ is a trademark of Biotium, Inc.
759137 Rev. 2
Antibody Details
Down Arrow Up Arrow
493

The 493 antibody reacts with a cell-surface protein of 130-140 kDa expressed on immature B lymphocytes and a small fraction of newly formed B cells, but not on mature B lymphocytes. The antigen's distribution was defined through the use of antibodies to CD24 (Heat Stable Antigen), IgM, IgD, and CD45R/B220, which are commonly used to discriminate B-cell maturation stages.  493 mAb reacts with the majority of B220+ cells in bone marrow and a fraction of B220+ B cells in spleen, which are CD24[high], IgM[high], and IgD[low].  Cells binding 493 mAb were not detected in thymus, lymph nodes, or peritoneal cavity. This result suggested that 493 mAb does not stain B-1 B cells (CD5+ B lymphocytes), which are particularly found in the peritoneal cavity.  The 493 mAb does not seem to have any biological effect when incubated with immature B lymphocytes.  It has been observed that the staining pattern of mAb 493 is similar to that of mAb AA4.1, that both antibodies precipitate molecules of the same molecular weight, and that staining by mAb AA4.1 is not blocked by mAb 493, suggesting that the antibodies recognize separate epitopes of the same Early B Lineage antigen.

759137 Rev. 2
Format Details
Down Arrow Up Arrow
RY610
The BD Horizon RealYellow™ 610 (RY610) Dye is part of the BD® family of yellow-green dyes. It is a tandem fluorochrome with an excitation maximum (Ex Max) at 557-nm and an emission maximum (Em Max) at 610-nm as measured using an antibody-dye conjugate. Driven by BD® innovation, RY610 can be used on both spectral and conventional cytometers and is designed to be excited by the Yellow-Green laser (561-nm) with minimal excitation by the 488-nm blue laser. For conventional instruments equipped with a Yellow-Green laser (561-nm), RY610 can be used as an alternative to PE-CF594 and we recommend using an optical filter centered near 610-nm (eg, a 610/20-nm bandpass filter). For spectral instruments equipped with a Yellow-Green laser (561-nm), it can be used in conjunction with PE-CF594.
altImg
RY610
Yellow-Green 561 nm
557 nm
610 nm
759137 Rev.2
Citations & References
Down Arrow Up Arrow
View product citations for antibody "759137" on CiteAb

Development References (3)

  1. Allman D, Lindsley RC, DeMuth W, Rudd K, Shinton SA, Hardy RR. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J Immunol. 2001; 167(12):6834-6840. (Biology). View Reference
  2. Rolink AG, Andersson J, Melchers F. Characterization of immature B cells by a novel monoclonal antibody, by turnover and by mitogen reactivity. Eur J Immunol. 1998; 28(11):3738-3748. (Immunogen). View Reference
  3. Rolink AG, Andersson J, Melchers F. Molecular mechanisms guiding late stages of B-cell development.. Immunol Rev. 2004; 197:41-50. (Clone-specific: Flow cytometry). View Reference
759137 Rev. 2

 

Please refer to Support Documents for Quality Certificates


Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described


Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims.  Comparisons are not made against non-BD technologies, unless otherwise noted.

For Research Use Only. Not for use in diagnostic or therapeutic procedures.